One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
ﻗﯿﻤﺖ : 300$- ﻗﯿﻤﺖ ﻭﯾﮋﻩ : 100$
Psoriatic arthritis: A comprehensive review for the dermatologist part I: Epidemiology, comorbidities, pathogenesis, and diagnosis
Psoriatic arthritis: A comprehensive review for the dermatologist–Part II: Screening and management
This month in JAAD International: May 2025: Body dysmorphic disorder and the theoretical underpinnings of a complex disease
Long-term evolution of prepubertal-onset anogenital lichen sclerosus: A 35-year retrospective and cross-sectional study from a single tertiary care maternal and pediatric center
Risk of major adverse cardiovascular events and venous thromboembolic events between patients with psoriasis or psoriatic arthritis on tumor necrosis factor inhibitors, interleukin 17 inhibitors, interleukin 12/23 inhibitors, and interleukin 23 inhibitors: An emulated target trial analysis
The efficacy of longer-term lebrikizumab treatment in patients with moderate-to-severe atopic dermatitis who did not meet protocol-defined response criteria at week 16 in 2 randomized controlled clinical trials
Effect of finger socks on clinical cure in interdigital tinea pedis
JAAD Game Changers: Pediatric melanomas often mimic benign skin lesions: A retrospective study
Interferon-α biological activity is associated with disease activity and risk of flare in cutaneous lupus erythematosus: A monocentric study of 184 patients
A 96-week real-world outcome of upadacitinib treatment for atopic dermatitis: Systemic therapy-naive versus -experienced patients
Predictors of perceived stress, perceived stigmatization, and body dysmorphia in patients with chronic prurigo/prurigo nodularis: Results from an observational cross-sectional multicenter European study in 17 countries
Prevalence of poor outcomes in cutaneous squamous cell carcinoma by AJCC and BWH tumor stages: A systematic review and meta-analysis
Nail unit melanoma treated with Mohs micrographic surgery: Technique, local recurrence rate, and surgical outcomes
JAAD Game Changers: Propranolol treatment of infantile hemangioma (IH) is not associated with developmental risk or growth impairment at age 4 years
Infrequent laboratory abnormalities during terbinafine therapy for onychomycosis: A retrospective cohort analysis within an integrated health system
Current evidence on safety of Janus kinase inhibitors in pregnancy and lactation
Long-term effectiveness and safety assessment of carbon dioxide laser treatment in Hailey-Hailey disease: A prospective cohort study
Limited efficacy of platelet-rich plasma intramatricial injections for idiopathic brittle nail treatment: A pilot intrasubject randomized controlled trial
Stigma underlies the mental health burden of pediatric atopic dermatitis: A cohort study
The spectrum of cutaneous and systemic manifestations associated with anti-PM/Scl: Insights from a single institution case series
Real-world experience of bimekizumab for plaque psoriasis in adult patients with prior exposure to interleukin-17 inhibitors: A 52-week multicenter retrospective review
Overall and subgroup prevalences of noninfectious uveitis among patients with hidradenitis suppurativa
Risk of interstitial lung disease in adult patients with dermatomyositis treated with methotrexate: A retrospective analysis of a prospective cohort
Black patients with Mycosis fungoides and Sézary Syndrome experience worse health-related quality of life: A cross-sectional study
Affordability matters: A cross-sectional study on sunscreen cost and application amount
A comparison of iPLEDGE requirements to risk mitigation programs for isotretinoin in other countries and to other teratogenic medications in the United States
Safety of beta blockers for the treatment of PHACE syndrome: AÂ systematic review
Limited and variable access to dermatologists among medicaid beneficiaries in the United States
Development of a treatment decision aid for patients with dysplastic nevi who are candidates for re-excision
Medicaid formularies for rosacea treatment are often restrictive and show inconsistency in transparency and coverage
Establishing minimally important difference thresholds for lesion counts in acne clinical studies
High rates of potentially unnecessary topical antifungal prescribing in a large commercial health insurance claims database, United States
Efficacy of hedgehog pathway inhibitors as adjuvant in treating steroid-refractory sclerodermatous chronic graft-versus-host disease
Abrocitinib interferes with the performance of T-SPOT.TB assay for latent tuberculosis reactivation: An in vitro study
Dupilumab and neuropsychiatric outcomes in pediatric atopic dermatitis: A real-world cohort analysis
Higher odds of dupilumab prescriptions for Black patients with atopic dermatitis: Results of a retrospective study using DataDerm, the database of the American Academy of Dermatology
Occupational formalin exposure from biopsy jars can be minimized by a modified collection procedure
Dupilumab treatment restores lesional and nonlesional skin barrier function in adults and adolescents with atopic dermatitis irrespective of the filaggrin genotype: Results from an open-label, healthy-control–matched, phase 4 clinical study (BALISTAD)
The presence of cutaneous lupus in systemic lupus erythematosus is associated with an increased risk of mental health disorders: a large-scale, retrospective cohort study
Comparing prescription drug saving platforms for dermatology: A cost analysis of Mark Cuban Cost Plus Drugs, GoodRx, and Amazon RxPass
Glucagon-like peptide-1 receptor agonist medications and hair loss: A retrospective cohort study
SCAR-ed by Antibiotics: A retrospective cohort study of severe cutaneous adverse reactions (SCAR) relative risk
Real-world experience of tralokinumab for atopic dermatitis: A 16-week multicenter retrospective study
Analysis of epidemiology and health care utilization for tinea nigra, white piedra, and black piedra among 39.4 million commercially insured outpatients, United States
Infection risk of rituximab monotherapy versus combination therapy with rituximab and mycophenolic acid in systemic sclerosis: A retrospective cohort study
Early inadequate response to biological agents portends treatment failure at 6Â months in patients with psoriasis: A multicenter, prospective cohort study
Combination of oral minoxidil and bicalutamide for the treatment of female pattern hair loss in adolescents
Pediatric primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: A retrospective analysis and review of the literature
Treatment of androgenetic alopecia with low-dose oral minoxidil monotherapy compared with combination therapy with dutasteride or finasteride
Discrepancies in patch testing timing and outcomes: A retrospective analysis of the Pediatric Allergic Contact Dermatitis Registry
JAAD Game Changers: Randomized controlled pilot study of the preoperative use of brimonidine 0.33% topical gel for hemostasis in Mohs micrographic surgery
High degree of variability and lack of transparency among private insurers for coverage of comprehensive patch testing
A call to action regarding the Risk Evaluation and Mitigation Strategy program for brodalumab
JAAD Game Changers: Utility of recorded guided imagery and relaxing music in reducing patient pain and anxiety, and surgeon anxiety, during cutaneous surgical procedures: A single-blinded randomized controlled trial
Dermatologists carrying forward the legacy of Rudolph Virchow: Lessons learned from Dr Ernesto González-MartÃnez
Ethical dilemma of billing for pathology of cosmetically removed skin lesions
Ethical implications of no-show fees in dermatology: Balancing practice needs and patient concerns
Ethical impact of physician voices in the arena of societal discourse
Hair removal through subcutaneous plane beyond the excision borders: AÂ new way to prevent recurrences in hidradenitis suppurativa
Ultraviolet-enhanced ex vivo dermoscopy: A novel approach for demodicosis
Response to Taylor et al, “Enhanced disease-specific survival in lentigo maligna melanoma patients treated with Mohs surgery over wide local excision: A retrospective cohort analysis of the Surveillance, Epidemiology, and End Results database�
Bridging the gap in acne vulgaris research for skin of color patients
Response to Fleshner et al, “Bridging the gap in acne vulgaris research for skin of color patients: Response to: “Assessing the inclusion of post-inflammatory hyperpigmentation outcomes in acne vulgaris clinical trials�
Response to Kang et al, “Efficacy of low-dose oral minoxidil in the management of anticancer therapy-induced alopecia in patients with breast cancer: A retrospective cohort study�
Response to Kearney et al, “Response to Kang et al, ‘Efficacy of low-dose oral minoxidil in the management of anticancer therapy-induced alopecia in patients with breast cancer: A retrospective cohort study’�
Comments on the increased risk of hidradenitis suppurativa in patients with human papillomavirus infection
Response to Chen et al, “Comments on the increased risk of hidradenitis suppurativa in patients with human papillomavirus infection�
Comments on “impact of delay of diagnosis of pyoderma gangrenosum on healing outcomes and health care utilization: A prospective cohort study�
Response to “Comments on “Impact of delay of diagnosis of pyoderma gangrenosum on healing outcomes and healthcare utilization: a prospective cohort study��
Response to Sood et al’s “Systemic Janus kinase inhibitor treatment for vitiligo: An evidence-based review�
Response to Vera et al’s “Interleukin-23 inhibition associates with lower incidence of cardiovascular risk factor type diseases compared to biologic naïve patients with psoriasis: A retrospective cohort study�
Response to Liu et al., “Response to Ormaza Vera et al. “Interleukin 23 inhibition associates with lower incidence of cardiovascular risk factor type diseases compared to biologic-naïve patients with psoriasis: A retrospective cohort study��
Limitations and risks of custom GPTs in dermatology. Comment on “ReconGPT: A novel artificial intelligence tool and its potential use in post-Mohs reconstructive decision-making�
Response to Wang et al's limitations and risks of custom GPTs in dermatology. Comment on “ReconGPT: A novel artificial intelligence tool and its potential use in post-Mohs reconstructive decision-making�
